메뉴 건너뛰기




Volumn 134, Issue 8, 2016, Pages 571-573

Randomized trials to evaluate cardiovascular safety of antihyperglycemic medications

Author keywords

diabetes complications; diabetes mellitus; empagliflozin; liraglutide; randomized controlled trials

Indexed keywords

ALEGLITAZAR; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EMPAGLIFLOZIN; GLUCOSE; LIRAGLUTIDE; PIOGLITAZONE; PLACEBO; SEMAGLUTIDE;

EID: 84983667048     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.021914     Document Type: Article
Times cited : (13)

References (6)
  • 4
    • 84983626370 scopus 로고    scopus 로고
    • Accessed May 4
    • Novo Nordisk website. http://www.novonordisk.com/media.html. Accessed May 4, 2016
    • (2016) Novo Nordisk Website
  • 5
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33
    • UK Prospective Diabetes Study
    • UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-853. doi: http://dx.doi.org/10.1016/S0140-6736(98)07019-6
    • (1998) Lancet , vol.352 , pp. 837-853


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.